Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.48 |
| ▸ | RARB | P10826 | 1/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.45 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628566 | 0.99 | RARB (0.49) | S1PR1S1PR3RARBLPAR1LPAR5 | |
| SCHEMBL20482319 | 0.96 | S1PR1 (0.51) | S1PR1S1PR3RARBLPAR1LPAR5 | |
| SCHEMBL21628676 | 0.92 | CA12 (0.43) | S1PR1S1PR3LPAR1LPAR5 | |
| SCHEMBL21628576 | 0.89 | MDH1 (0.52) | S1PR1S1PR3RARBLPAR1LPAR5 | |
| SCHEMBL21628573 | 0.88 | MDH1 (0.51) | S1PR1S1PR3RARBLPAR1LPAR5 | |
| SCHEMBL21628653 | 0.88 | CA12 (0.47) | LPAR1LPAR5 | |
| SCHEMBL21628540 | 0.87 | RARB (0.62) | S1PR1S1PR3RARBLPAR1LPAR5 | |
| SCHEMBL21628866 | 0.86 | RARB (0.65) | RARBLPAR1LPAR5 | |
| SCHEMBL21628639 | 0.86 | S1PR1 (0.52) | S1PR1S1PR3RARBLPAR1LPAR5 | |
| SCHEMBL21628589 | 0.86 | S1PR1 (0.52) | S1PR1S1PR3RARBLPAR1LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | S1PR1 3152/4885S1PR3 2888/4885RARB 1144/4885 |
| US-20220348535-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | S1PR1 3152/4885S1PR3 2888/4885RARB 1144/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | S1PR1 3184/4885S1PR3 2958/4885RARB 1064/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | S1PR1 3152/4885S1PR3 2888/4885RARB 1144/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | S1PR1 1335/4885S1PR3 1310/4885RARB 1531/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | S1PR1 3152/4885S1PR3 2888/4885RARB 1144/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | S1PR1 3152/4885S1PR3 2888/4885RARB 1144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.